Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.68B |
| 2 |
Synchrony
SYF
|
+$441M |
| 3 |
Meta Platforms (Facebook)
META
|
+$370M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$349M |
| 5 |
Comcast
CMCSA
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$783M |
| 2 |
Morgan Stanley
MS
|
+$518M |
| 3 |
Lowe's Companies
LOW
|
+$474M |
| 4 |
Visa
V
|
+$425M |
| 5 |
Netflix
NFLX
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.01% |
| 2 | Technology | 4.76% |
| 3 | Consumer Discretionary | 3.82% |
| 4 | Industrials | 3.81% |
| 5 | Communication Services | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
1926
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
| $8.89M | ﹤0.01% |
785,100
+219,800
| +39% | +$2.87M |
|
|
K
1927
PUT
DELISTED
Kellanova
K
| $8.87M | ﹤0.01% |
165,714
+10,437
| +7% | +$630K |
|
1928
CALL
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
| $8.87M | ﹤0.01% |
101,800
+22,300
| +28% | +$1.89M |
|
1929
iShares MSCI Netherlands ETF
EWN
$738M
| $8.85M | ﹤0.01% |
336,446
+300,957
| +848% | +$8.43M |
|
|
CSGS
1930
DELISTED
CSG Systems International
CSGS
| $8.82M | ﹤0.01% |
277,781
+15,660
| +6% | +$550K |
|
|
BBBY
1931
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $8.82M | ﹤0.01% |
779,000
-64,600
| -8% | -$844K |
|
1932
PUT
Energy Transfer Partners
ET
$72.5B
| $8.81M | ﹤0.01% |
666,900
+308,800
| +86% | +$4.69M |
|
1933
PUT
First Solar
FSLR
$24.2B
| $8.81M | ﹤0.01% |
207,500
-158,900
| -43% | -$6.98M |
|
1934
PUT
Genuine Parts
GPC
$18.6B
| $8.8M | ﹤0.01% |
91,700
+18,000
| +24% | +$1.78M |
|
1935
CALL
Jabil
JBL
$38B
| $8.8M | ﹤0.01% |
355,100
+324,900
| +1,076% | +$7.93M |
|
1936
PUT
Zoetis
ZTS
$30.5B
| $8.8M | ﹤0.01% |
102,900
+5,500
| +6% | +$495K |
|
1937
Myriad Genetics
MYGN
$290M
| $8.8M | ﹤0.01% |
302,790
+84,024
| +38% | +$3.02M |
|
1938
Penumbra
PEN
$12.9B
| $8.79M | ﹤0.01% |
71,893
-31,730
| -31% | -$4.25M |
|
1939
BJ's Restaurants
BJRI
$1.45B
| $8.78M | ﹤0.01% |
173,669
-19,053
| -10% | -$1.15M |
|
1940
iShares Core S&P US Growth ETF
IUSG
$33.9B
| $8.78M | ﹤0.01% |
166,639
+129,343
| +347% | +$7.33M |
|
1941
CALL
Corpay
CPAY
$27.4B
| $8.77M | ﹤0.01% |
47,200
-52,500
| -53% | -$10.3M |
|
1942
Under Armour Class C
UA
$2.26B
| $8.76M | ﹤0.01% |
+541,923
| New | +$10.3M |
|
1943
CALL
Ligand Pharmaceuticals
LGND
$5.87B
| $8.75M | ﹤0.01% |
103,394
+38,633
| +60% | +$4.12M |
|
1944
Brunswick
BC
$5.36B
| $8.75M | ﹤0.01% |
188,419
-205,353
| -52% | -$11M |
|
1945
Abercrombie & Fitch
ANF
$4.8B
| $8.74M | ﹤0.01% |
435,874
+260,166
| +148% | +$4.87M |
|
1946
CALL
T. Rowe Price
TROW
$23.6B
| $8.73M | ﹤0.01% |
94,600
+27,900
| +42% | +$2.71M |
|
1947
Prestige Consumer Healthcare
PBH
$2.43B
| $8.73M | ﹤0.01% |
282,608
-75,787
| -21% | -$2.77M |
|
|
ACHN
1948
DELISTED
Achillion Pharmaceuticals
ACHN
| $8.72M | ﹤0.01% |
5,487,094
+1,311,839
| +31% | +$3.71M |
|
1949
NovoCure
NVCR
$1.97B
| $8.72M | ﹤0.01% |
260,416
+199,111
| +325% | +$7.28M |
|
|
SINA
1950
DELISTED
Sina Corp
SINA
| $8.71M | ﹤0.01% |
162,475
+100,463
| +162% | +$6.21M |
|
Similar funds
Ken Griffin's Q4 2018 Portfolio in Review
As of Q4 2018, Ken Griffin held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Assurant worth $99.4M.
- Ken Griffin's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
- Ken Griffin added most to Amazon in Q4 2018, an estimated $1.68B increase.
- Ken Griffin's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
- Ken Griffin fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
- Ken Griffin's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
- Ken Griffin opened 1,237 new positions and closed 1,371 in Q4 2018.
- Ken Griffin's portfolio value fell 19% quarter-over-quarter to $183B.
Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.